Due to injuries, Rafael Nadal and Carlos Alcaraz will not compete in the Monte Carlo Masters.

As he continues to make progress in his recovery from a hip injury, Rafael Nadal skipped both the Indian Wells and Miami Open tournaments last month; as a result of the injury, he will not participate in the Monte Carlo Open, which kicks off the clay court season; Carlos Alcaraz, who has also had a difficult start to the season due to injuries, will not compete either.
Rafa Nadal will not compete in the Monte Carlo Masters because he was unable to recuperate in time from an injury that has kept him out of action for months. In addition, the world’s No. 2 tennis player, Carlos Alcaraz, has also withdrawn from the competition.

As Nadal continues to make progress in his recovery from a hip injury that forced him to withdraw from the Australian Open in the second round in January, the Masters 1000 tournament that was held in Indian Wells a month ago and the Miami Open that just concluded a week ago were both forced off the schedule.
Nadal stated, “Unfortunately, I am still not ready to compete, and as a result, I will miss one of those great tournaments that I always enjoy to play.”

“Monte Carlo is and has been an important event in my career, but regrettably I will have to skip it again because I am still not ready to compete without the risk of getting injured.” “Monte Carlo is and has been a key event in my career.” I shall carry on with the preparations necessary for my return.
Nadal has fallen four spots to 13th in the rankings as a result of his absence from contests in recent days, bringing an end to his record-setting 912-week stint inside the top 10.

Links Provided by Sponsors
Recommendation from
What exactly is an Outbrain?
Now is the time to compare top life insurance plans.
Now is the time to compare top life insurance plans.
The Top 10 Companies Offering Life Insurance | Search (Search ads)
The influence of “Iron Man” The sale of the “Razor House” took place for $20.8 Million
The influence of “Iron Man” The sale of the “Razor House” took place for $20.8 Million
(The Mansion Global Company)
Gene Simmons, lead singer for KISS, has called it a night in Las Vegas.
Gene Simmons, lead singer for KISS, has called it a night in Las Vegas (Mansion Global)
25 Stock Suggestions to Help You Build a Portfolio That Will Double Your Investments (Research & Ranking)
Find Reasonable Costs for Life Insurance
Find Reasonable Costs for Life Insurance
This Is How You Can Obtain Low-Cost Life Insurance in a Matter of Minutes | Search (Search ads)
Zahnimplantate in der Turkei: Preisliste Zahnimplantate in der Turkei: Preisliste (Suchanzeigen)
The newly appointed Chinese ambassador indicates a strong desire to strengthen ties with North Korea.
The newly appointed Chinese ambassador indicates a strong desire to strengthen ties with North Korea.
(Nikkei Asia)
The banana island is a paradise suitable for billionaires.
The banana island is a paradise suitable for billionaires.
(The Mansion Global Company)
A tax break for electric vehicles in the United States excludes imports, dealing a blow to the automotive industries in Japan and Europe.
A tax break for electric vehicles in the United States excludes imports, dealing a blow to the automotive industries in Japan and Europe.
(Nikkei Asia)
Boris Johnson Is in the Process of Acquiring an Ancient Moated Home in Oxfordshire That Is 400 Years Old
Boris Johnson Is Purchasing an Ancient Moated Home in Oxfordshire That Is 400 Years Old
(The Mansion Global Company)
Carra and Neville get into an argument over Kane’s ’embarrassing’ behaviour. Klopp: In my lineup, only two or three Liverpool players have certain starting berths.
Transfer Centre LIVE! Favorite candidate for the post at Chelsea; five candidates remain under consideration
Bruno: The circumstance is difficult, and I’m here because of Potter.
Khan was disqualified for violating the anti-doping policy, and he stated, “I’ve never cheated in my life.”
Tottenham needs a signature look more than they need a “champion.”
PL Predictions: There will be no management changes at Chelsea or Leicester.
On May 27, Okolie will defend his world title against Billam-Smith in a fight that will be shown live on Sky.
Chelsea is impressed with Nagelsmann, but there is some anxiety regarding his age | Who are the potential candidates?
Carra: Spurs are in shambles under Conte-lite | Neville: There has been little difference under Stellini Video Latest News
The Spaniard, who has won Monte Carlo 11 times in his career, is still hopeful that he will be healthy enough to compete in the French Open in May. The French Open is played on clay courts, and the Spaniard has dominated this tournament for many years, having won it 14 times.

As a result of his injury-plagued start to the season, Alcaraz will not participate in the tournament either. The young man, who is only 19 years old, was most recently seen competing in the Miami Open, where he was eliminated in the semi-finals by an Italian player named Jannik Sinner.
“After two months of competing, I am delighted to be back home but sad that I concluded my semi-final play in Miami with discomfort,” the winner of the US Open said in a statement on social media. “After two months of competing, I am sorry that I finished my semi-final match in Miami with discomfort.”

“I went to see my doctor today… and after being examined, it has been determined that I will not be able to travel to Monte Carlo to begin the clay court tour.

I have post-traumatic arthritis in my left hand, and I have muscle stiffness in my spine, both of which require rest in order for me to be able to deal with everything that is going to happen.

Felix Auger-Aliassime, a Canadian who is rated seventh in the world and who has been having issues with his left knee, is another competitor who has withdrawn from the Monte Carlo tournament.

On social media, he explained his decision to skip the next Madrid Open by saying, “[I] believed it was the smartest decision to take some time off so I’m able to fully heal and recover before my next competition at the Madrid Open.”

Lifestyle News

Amir Khan’s victory compared to Kell Brook’s disqualification due to his drug ban

Since Amir Khan was given a two-year doping penalty by the UK Anti-Doping Agency, the outcome of his bout against Kell Brook would no longer be considered official.

After adopting Khan’s position that the presence of ostarine in his system was not purposeful, UKAD said in a statement that the length of Khan’s suspension will be reduced from four to two years.
The United Kingdom Anti-Doping Agency (UKAD) issued the following statement regarding the panel’s findings: “The panel found both violations proved, judged that Mr. Khan had established that they were not ‘intentional’ within the sense of ADR Article 10.2.3, and imposed a two-year ban on him.”

Amir Khan vs Kell Brook result
“The referees also ruled that Mr. Khan’s result from his fight against Mr. Brook should not stand.
It is presumed that Mr. Khan’s two-year suspension began on April 6, 2022, which was the date when his provisional suspension was handed down. It will become invalid on April 5th, 2024.”

Khan was knocked out regardless of what was in his body, therefore it is impossible to say what this means for Brook. The Sheffield guy knocked out Khan. Injustice would be done to Brook, a former world champion, if his victory were to be taken away from him.

After a career that saw him become a superstar in his native Pakistan and win a silver medal at the Olympics in 2004, the legacy of Khan has been tainted.
In the end, the fighter from Bolton would compete against the likes of Marcos Maidana and Zab Judah to unify the super lightweight class. Khan was also presented with the World Boxing News Fighter of the Year Award in 2010, an honour which he did not take possession of until a few years later.

For the past ten years, he has seen his career decline. Despite this, Khan continued to compete in the sport through 2016, taking on Canelo Alvarez and Terence Crawford before retiring after his bout with Brook in 2022.

This drug test result should make Khan’s followers feel sick to their stomachs. This is the case despite the fact that the youthful prodigy they referred to as “King” asserts that he did nothing wrong.
According to a statement issued by UKAD, Khan is prohibited from competing in a variety of sports in addition to boxing.
Amir Khan gets disqualified from all athletic competition for a period of two years. Khan is a professional boxer and an Olympic medalist. The Anti-Doping Rule Violation (ADRV) that was committed for the presence and use of a Banned Drug has led to this consequence.

Regarding the component that was found, ostarine, they supplied the following information: “Ostarine is a selective androgen receptor modulator” (SARM).

The World Anti-Doping Agency (WADA) has included the drug on its list of substances that will be banned in 2022. Because it is an anabolic agent, its use is strictly forbidden in competitive sports.

The sanction meted out to Khan is just another black eye for the sport of boxing in the United Kingdom. The sickener comes after Conor Benn was investigated for failing two tests in 2022, the same year as his compatriot, which led to the investigation.

In recent years, the sport of boxing on the British Isles has become increasingly polluted by drug scandals. Meanwhile, the rest of boxing has seen fewer positive outcomes than the UK combined.


The manufacturer of the eye drops related to the deadly outbreak fails an inspection by the FDA.

At the facilities of Global Pharma, the FDA discovered brown slime and a lack of sterility tests.
According to an inspection report that was made public by the Food and Drug Administration (FDA), the manufacturer of the eye drops that have been linked to a deadly outbreak of extensively drug-resistant infections in the United States had a slew of manufacturing violations. These violations ranged from brown slime on filling equipment to a lack of basic measures and systems to ensure sterility (PDF).
Consumers were issued a warning in February to immediately discontinue the use of eye drops and eye ointment manufactured by Global Pharma. The company’s products were marketed in the United States under the brand names EzriCare and Delsam Pharma and were distributed by a variety of retailers including Amazon, Walmart, eBay, and others. In later years, recalls of the products were issued voluntarily by Global Pharma.
Investigators looking into matters pertaining to public health have established a connection between the drops and cases of a strain of Pseudomonas aeruginosa that was highly resistant to multiple antibiotics and was previously unknown in the United States. The strain is known as VIM-GES-CRPA, which is an abbreviation that stands for a carbapenem-resistant P. aeruginosa (CRPA) with Verona integron-mediated metallo—lactamase (VIM) and Guiana extended-spectrum—lactamase (GES). EzriCare was by far the most common brand of eye drop that afflicted individuals reported taking, despite their use of many other brands. In addition, the epidemic strain was found in opened bottles of EzriCare artificial tears, according to testing conducted by the Centers for Disease Control and Prevention as well as by researchers working independently.

According to reports from the Centers for Disease Control and Prevention (CDC), as of March 14 there have been 68 cases of infection with the strain across 16 states. As a result of the virus, three persons have passed away, eight others have suffered visual loss, and four more have had their eyeballs surgically removed.

The FDA found multiple production violations at Global Pharma back in February, but the inspection report details the full scope of the company’s failings. An inspection of Global Pharma’s production facility in Thiruporur, India (located just south of Chennai in the state of Tamil Nadu), which took place between February 20 and March 3 and resulted in a 14-page report, was conducted between February 20 and March 3.

The report of the inspection details eleven “observations” of problems, along with specifics about each one. The first problem is that Global Pharma doesn’t appear to have bothered to check whether or not the eye drops it sells are in fact sterile, despite the fact that it has stated that they are. According to the FDA inspection report, the filtering technology used by the manufacturer cannot “reliably sterilise” the eye drops since there is “not appropriate validation evidence to establish” that it can do so.
Fatal inadequacies
It appeared as though the facility was set up to manufacture things that were tainted. Inspectors from the FDA stated that Global Pharma did not check to ensure that the components of the solutions, which were purchased from suppliers, were sterile from the beginning. In addition, the portions of the facility that were supposed to be used for making the solution in an aseptic, or contamination-free, manner were not suitable for the production of sterile goods. That is to say, the surfaces of the walls, ceilings, and floors were not smooth and firm, as they should have been so that they could be easily disinfected. On the contrary, there were holes, fissures, and nails that were sticking out of the wall. According to the investigation, however, even if it were possible to clean the area, the company’s procedures for doing so were not up to par.

Inspectors from the FDA found issues with the cleanliness and upkeep of the machinery, which might have resulted in cross-contamination from other items made at the plant. On the second day of the inspection, an inspector saw a “black, brown coloured greasy layer” on portions of the filling machine. The equipment logbook for the facility stated that it hadn’t been cleaned in about a month, which was mentioned in the inspector’s observation. A management explained to the inspector a few days later that there was “no method for cleaning” the filling machine.
According to the findings of the investigation, environmental monitoring in the facility to look for signs of contamination was nonexistent. In addition, the sterility of the primary packaging, which included the tops of the bottles, was not checked before it was used. After the eye drops had been bottled, the formulation did not include a preservative to protect against the growth of microorganisms, and batches were shipped to the United States without first passing through the quality control unit.

Earlier, a CDC official expressed her concern to Ars about the epidemic of VIM-GES-CRPA in the United States, saying that she believed it might seed more infections and medication resistance. According to Marissa Grossman, who works for the CDC’s epidemic intelligence branch, “to far, widely drug-resistant Pseudomonas with genes that rapidly propagate resistance, like VIM and GES, have been uncommon in this nation.” She said that the extensive introduction of the epidemic strain poses a threat to efforts to prevent highly resistant organisms from becoming more common. “The widespread introduction of the outbreak strain…”

The Food and Drug Administration (FDA) issued recall letters for two additional brands of eye drops in the month of March, namely those manufactured by Pharmedica and Apotex. The epidemic of VIM-GES-CRPA has not been linked to any of the products, which both state on their labels that they were made in North America.

News Technology

According to recent reports, SpaceX may conduct an orbital test flight of the Starship vehicle the following week.

As soon as the following week, SpaceX’s massive Starship Mars rocket might make its initial attempt to enter orbit for the first time.

The Starship that SpaceX is constructing will be able to transport passengers and freight to destinations beyond the moon and Mars. Both the massive first-stage booster known as Super Heavy and the upper-stage spaceship known as Starship in the deep space transit system are planned to be totally reusable. Super Heavy is the name of the booster, while Starship is the name of the upper-stage spacecraft.

Since the beginning of this year, SpaceX has been preparing for the very first orbital test flight of a Starship spacecraft. This historic mission will be carried out by the Super Heavy prototype Booster 7 and a Starship vehicle with the designation Ship 24.
Elon Musk, founder and CEO of SpaceX, stated in the middle of March that the historic mission, which would take out from SpaceX’s Starbase facility in South Texas, might perhaps launch as early as the third week of April. Yet new information and events point to the possibility that the attempt might occur even sooner than that.
For instance, over the weekend, many Starship observers noticed that SpaceX rolled Ship 24 out to Starbase’s orbital launch pad (opens in new tab). In addition, the corporation carried out fueling tests with Booster 7(opens in new tab) while it was mounted on the orbital launch platform on Monday (April 3), while Ship 24 was positioned on the ground nearby.

In addition, as reported by a satellite tracker based in the Netherlands named Marco Langbroek, navigational warnings have been issued in preparation for the Starship’s attempt to enter orbit (opens in new tab). These alerts cover the period from April 6 through April 12 inclusive.

It would indicate that SpaceX has no intention of attempting to reach the earlier portion of the projected timeframe. First off, according to what Elon Musk mentioned around a month ago, the corporation is still waiting for a launch licence from the Federal Aviation Administration in the United States.
Nonetheless, Eric Berger of Ars Technica believes that April 10 or April 11 are also viable options for the date of the event.

According to what Berger reported over the weekend, NASA appears to be making preparations to make a provisional reservation for “the use of its high-altitude WB-57 aircraft for observations of the Starship test mission on April 10 and 11.” (opens in new tab). Because NASA plans to utilise the Starship vehicle as a lunar lander for its astronauts as part of the Artemis moon missions, the organisation is keeping a close eye on SpaceX’s development with the big rocket.

During the orbital test flight, an attempt will be made to send Ship 24 on one lap around the Earth. The test flight will culminate with Ship 24 splashing down in the Pacific Ocean close to the island of Kauai in Hawaii.

Musk previously stated that there is approximately a 50% probability that Starship would succeed on its first attempt. But SpaceX is currently working on multiple Starship prototypes at Starbase, and once they are complete, the company intends to launch them in pretty short succession one after the other.

During an interview on March 7 at the Morgan Stanley Conference, Elon Musk remarked, “So I think we’ve got, hopefully, around an 80% chance of reaching orbit this year” (opens in new tab).

Mike Wall is the author of the book “Out There,” which was published in 2018 by Grand Central Publishing and was illustrated by Karl Tata. This book is about the quest for extraterrestrial life. You may find him on Twitter under the handle michaeldwall (opens in new tab). You can follow us on Twitter (@Spacedotcom) or on Facebook (opens in a new tab) (opens in new tab).

Join our Space Forums to continue the conversation about space, including the most recent space missions, the night sky, and more! In addition, please contact us at communit[email protected] if you have any comments, corrections, or news tips.


“Beginning hormone therapy at the outset of menopause does not increase the risk of Alzheimer’s disease.”

According to the findings of recent studies, women who begin hormone treatment (HT) at the beginning of menopause do not have an increased risk of developing Alzheimer’s disease, despite the possibility that early menopause is a risk factor for the condition.

Women have a higher risk of developing Alzheimer’s disease than males do, and women now make up the majority of those who are afflicted with the disease.

A new, limited study has been published that offers insight on the association between the risk of Alzheimer’s disease and factors such as age at menopause and use of hormone replacement therapy, generally known as HT (HRT).


According to the data, starting hormone therapy later in life may be associated with an increased risk of Alzheimer’s disease.
According to the researchers who conducted the study, the findings lend credence to the guidelines that advise hormone therapy should begin relatively soon to the onset of menopause rather than a few years later.

“HT is the most consistent technique to relieve severe menopause symptoms,” said Rachel Buckley, of the Department of Neurology at Massachusetts General Hospital (MGH), which is located in the United States. Yet, throughout the past few decades, there has been a lack of clarity on how HT affects the brain.

“We found that the highest levels of tau, a protein involved in Alzheimer’s disease, were only observed in hormone therapy users who reported a long delay between age at menopause onset and their initiation of hormone therapy.” [Citation needed] “We found that the highest levels of tau, a protein involved in Alzheimer’s disease,”

“The hypothesis that tau deposition may be the underlying cause of the link between late hormone therapy intervention and Alzheimer’s disease dementia was a monumental result because it was something that had never been seen previously,” the researchers said.

Past research has found a correlation between early menopause and an increased likelihood of developing Alzheimer’s disease dementia. Premature menopause is defined as menopause that occurs naturally before the age of 40 or due to surgical intervention before the age of 45.
Hormone therapy is used to alleviate the severe symptoms associated with menopause, and previous research has showed that it may also be able to prevent cognitive decline.

The women’s health initiative (WHI) study, which was conducted 20 years ago, found that the use of hormone therapy (HT) was associated with a nearly two-fold higher incidence of dementia compared to a placebo among women aged 65 years and older. This may have been caused by the fact that women began using HT many years after the onset of menopause.

The current study used brain imaging to investigate the relationship between the presence of beta-amyloid and tau, two proteins implicated in Alzheimer’s dementia, and the age at which a woman entered menopause as well as the consumption of HT.

In order to establish the levels of amyloid and tau in seven different regions of the brain, the researchers looked at scans taken from 292 adults with normal cognitive function.

The study found that women had higher amounts of tau compared to men of the same age, particularly in instances where the women also had elevated levels of beta-amyloid.

On the other hand, the researchers discovered that the relationship between aberrant levels of the proteins was significantly stronger among women who entered menopause at a younger age.

In the sections of the brain that are known to play a role in the course of Alzheimer’s dementia, the levels of tau were found to be elevated. These regions of the brain are located near to the brain’s memory centre.

Researchers investigated whether or not the use of HT was connected with the two proteins because a large number of women who experience premature menopause also use HT.

Researchers found that commencing the therapy late – five years or more after menopause – was the driving factor behind this relationship, despite the fact that the study verified this association.

A significant number of the women who fell into the late-HT-initiation category did not begin therapy until over ten years following menopause.

According to the study’s first author, Gillian Coughlan, who works in the Department of Neurology at the Massachusetts General Hospital, up to ten percent of women go through a premature or early menopause. Our findings suggest that an earlier age at menopause may be a risk factor for Alzheimer’s disease dementia.

“Hormone medication can have negative consequences on cognition, but only if the treatment is started several years after the age at which a woman enters menopause.”

“Our observational findings lend support to clinical guidelines that suggest hormone therapy ought to be administered soon to the onset of menopause, but not several years following,” the authors write.

The findings were presented in a paper that was published in JAMA Neurology.

“While we understand that news like this can seem concerning, this study does not show that hormone therapy causes Alzheimer’s,” said Dr. Sara Imarisio, head of research at Alzheimer’s Research UK. “While we understand that news like this can seem concerning, this study does not show that hormone therapy causes Alzheimer’s.”

Because the researchers did not follow up to see if the subjects went on to develop signs of dementia, we are unable to draw any conclusions about the relationship between cause and effect from this type of study.

She went on to say that “Hormone therapy gives important benefits to a large number of women, helping to counteract the problems that can be brought on by menopause.”

“Women who now take hormone therapy or are considering about taking it should not be dissuaded from doing so by these results,” and “anyone concerned about the effects of this treatment should consult with their doctor.”

A study that was conducted by experts at the University of East Anglia in January revealed that HRT may help prevent Alzheimer’s disease in women who are at risk of developing the condition.

The use of HRT, which helps control symptoms of the menopause, is associated with better memory, cognitive function, and larger brain volumes in later life in women carrying a gene called It is believed that approximately one quarter of women in the UK carry the APOE4 gene, and Alzheimer’s disease is more common in women than in men.

The study indicated that HRT was most effective when administered during perimenopause, which is the period of time months or years before to the cessation of menstruation during which symptoms of menopause begin to develop. This could result in brains that appear several years younger.


A few days after he sought a judge to throw out a $258 billion racketeering lawsuit accusing him of running a pyramid scheme to support the cryptocurrency Dogecoin, Elon Musk replaced the bird icon that represented Twitter with a cartoon version of the cryptocurrency’s mascot.

It comes as Musk’s attorneys have argued that the controversial CEO has not tweeted anything that might be considered ‘illegal.’
Dogecoin investors accused Musk of operating a pyramid scheme using their cryptocurrency.
Yesterday morning, the blue bird emblem that serves as Twitter’s logo was changed with an image of a Shiba Inu. This change was made in reference to Dogecoin, the parody cryptocurrency that CEO Elon Musk is being sued for.

The controversial head of social media, who bought Twitter in a deal worth $44 billion last year, addressed the change on Monday afternoon. He Tweeted an image of a conversation from the previous year, in which another user recommended that Musk “simply buy Twitter” and “change the bird logo to a doge.”

After only two days, the new joke logo appeared on the site, and shortly after that, Elon Musk asked a judge to dismiss a $258 billion racketeering lawsuit accusing him of running a pyramid scheme to support the dogecoin. The lawsuit alleges that he supported the dogecoin through the use of dogecoins.
It is not yet apparent whether the altered logo was intended to be taken seriously and made permanent or whether it was purely sarcastic.

The lawsuit that was filed by investors of Dogecoin was referred to as a “fanciful piece of fiction” by Musk and the lawyers for Tesla. The case was filed because of the CEO’s “innocuous and often foolish Tweets.”

The attorneys stated that the investors never explained how Musk intended to defraud anyone or what risks he concealed, and that Musk’s statements such as “Dogecoin Rulz” and “no highs, no lows, only Doge” were too vague to support a fraud claim. The lawyers also stated that the investors never explained how Musk intended to defraud anyone.

“There is nothing unlawful about tweeting words of support for, or humorous photos about, a genuine cryptocurrency that continues to retain a market cap that is approximately $10 billion,” Musk’s lawyers stated. “There is nothing unlawful about tweeting words of support for, or funny photographs about,” “This court ought to put an end to plaintiffs’ delusion and throw out the complaint,” the argument goes.

The investors’ contention that Dogecoin met the qualifications of a security was another one that the attorneys refuted in a footnote.

Evan Spencer, the attorney for the investors, stated in an email stating the following: “We are more certain than ever that our case will be successful.”

Investors have accused Elon Musk, the second-richest person in the world according to Forbes, of artificially inflating the price of dogecoin by more than 36,000 percent over the course of two years and then allowing it to crash.
They claimed that this resulted in profits of billions of dollars at the expense of other investors in Dogecoin, despite the fact that Musk was aware that the currency lacked any inherent value.

Investors also alluded to Musk’s performance on a segment of NBC’s “Saturday Night Live” dubbed “Weekend Update,” in which he portrayed a bogus financial adviser and referred to Dogecoin as “a scam.”

The sum of $258 billion in damages is three times higher than the expected fall in the value of dogecoin’s market during the thirteen months prior to the filing of the case.

The Dogecoin Foundation, a charitable organisation, is also a defendant in this case and wants it to be dismissed.

Several legal actions have been taken as a direct result of Musk’s postings on Twitter, which he controls.

On February 3, a jury in San Francisco held him not responsible for tweeting in August 2018 that he had acquired finance to take Tesla private. This result brought him a legal triumph in the court system.

Over the course of the last day and a half, the price of the notoriously unstable cryptocurrency Dogecoin increased by almost 20% to approximately 9 cents.

It has been trading for slightly less than 8 cents as of the morning of Monday.
A joke between two software developers in 2013 resulted in the creation of the cryptocurrency known as dogecoin.

The name is a reference to the internet craze known as “doge,” which sprang to prominence a decade ago.


Christina Hammock Koch, a NASA astronaut, will make history by becoming the first woman to orbit the moon.

April 3 (UPI) — When the Artemis II mission is launched by NASA the following year, astronaut Christina Hammock Koch, who is currently serving as a flight engineer on the International Space Station and holds the record for the longest single spaceflight by a female, will become the first woman to orbit the moon. Koch will do so as part of the Artemis II mission.

On Monday, it was announced that astronaut Christina Koch will be part of the team of four people from the United States and Canada who will travel around the moon. Koch, who was given the role of mission specialist, will be joined on the mission by astronauts from the Canadian Space Agency and NASA, including G. Reid Wiseman and Victor J. Glover Jr., who will make history as the first person of colour to orbit the moon, according to an announcement made by NASA and the Johnson Space Center on Monday in Houston, Texas.
In a video posted by NASA on Monday, Koch was quoted as saying, “When I first found out I was assigned to Artemis II, my thoughts were disbelief, an immense sense of honour and responsibility, and readiness; ready to try to make everyone proud and to really fulfil what this mission truly means for all humanity.” Koch’s comments were in response to the news that he would be serving on Artemis II.
Koch spent his childhood in Jacksonville, Florida, and received his education at the North Carolina School of Science and Mathematics in Durham before enrolling at North Carolina State University. Koch was appointed an astronaut in the year 2013. Koch has a Bachelor of Science degree in electrical engineering, in addition to a Bachelor of Science degree in physics, and a Master of Science degree in electrical engineering. In 2019, she addressed graduates of NC State University while she was aboard the International Space Station.
Koch advised the grads, “Don’t think there’s just one method to accomplish your dreams or a series of boxes you have to tick through life,” as they were receiving their degrees. “Let your life be guided by the things that you are most interested in and passionate about.”

After working as an electrical engineer at Goddard Space Flight Center (GSFC), Koch enrolled in the NASA Academy programme at Goddard Space Flight Center in 2001. Koch was one of the eight people chosen to be a part of the 21st class of NASA astronauts in 2013. Koch became an astronaut in 2013. 2015 was the year when she finished her training to become an astronaut candidate.

“For the most part, I can’t remember a period of my life when I wasn’t interested in being an astronaut. Ever since I can remember, this is the kind of thing I’ve always pictured myself doing “Koch stated this on Monday.
During Expeditions 59, 60, and 61 aboard the International Space Station, Koch was the flight engineer. Her maiden trip in orbit, which took place aboard the International Space Station and lasted for an extended period of time, was scheduled to begin in 2018. Koch set a record for the longest single spaceflight by a woman when she blasted off from the Baikonur Cosmodrome on a Soyuz spacecraft on March 14, 2019, and returned to Earth on February 6, 2020. She also set a record for the second longest single spaceflight by a U.S. astronaut, following in the footsteps of retired astronaut Scott Kelly. Koch was away from Earth for a total of 328 days, which prompted her to share a video of her rescue dog’s excited reaction to her return when she was finally back on Earth.
Koch also participated in a total of six space walks during the time that she was stationed at the International Space Station (ISS). These space walks include the first all-female spacewalk, which NASA at first cancelled because it did not have enough woman-sized space suits. In the end, Koch was the one who participated in the spacewalk alongside male astronaut Nick Hague while wearing one of the medium-sized spacesuits.

NASA stated in March of 2019 that Koch will be the one to wear the medium-sized torso because only one could be completed in time for Friday.
During their time aboard the International Space Station, Koch and the other members of her crew participated in hundreds of experiments designed to further knowledge in the fields of Earth science, physical science, biology, human study, and technology.

Koch reflected on her time spent in Ghana nearly two decades ago when she posted a picture on her Instagram account in 2019 showing the Ghanaian flag floating in space.

“When I was 20 years old, I went to the University of Ghana to pursue my education abroad. It was a great event that changed my life and deepened my viewpoint, similar to going into space “Koch wrote.

One year later, Koch assisted Nickelodeon in the launch of the children’s cable network’s first film of the network’s trademark green slime in orbit. Koch and another member of the group were able to stick the slime to a paddle board by spinning it in the air while holding it there. Despite the absence of gravity, they were unable to dump it on top of each other’s heads.

Koch remarked that “playing with slime in space is considerably more enjoyable than I expected it would be,” in addition to being “way more unpredictable.” “Much as with all of the other scientific work that we perform, it is not possible to do these tests on Earth; you require zero gravity to witness some of this behaviour.”

When Koch uploaded her final snapshot of Earth in a tweet in 2020 as she returned from the International Space Station, she was met with backlash from people who believe in the existence of a flat Earth. Some of the responses she received included the phrases “false photograph” and “great fake curvature.”
And Koch continued to post her images from her flights, including one that was reminiscent of a painting by Vincent van Gogh and featured a starry night that Koch had taken while aboard the International Space Station.

“City lights, stars, lightning storms, and even satellite flares — this is a composite of separate photographs built on top of each other to depict all of the incredible things that we view when we look out our window at night.”
While Koch will be part of the Artemis II crew that will orbit the moon in 2024, it is anticipated that a different crew, which will not be named, would land on the moon in 2025.

Koch expressed excitement about the opportunity to collaborate with the other members of the Artemis II team on Monday.

“They all have a military history and I come from a more raw technical engineering background, and I think it complements each other extremely well,” Koch said. “I come from a more raw technical engineering background.” “I believe that we will work together very well, and I hope to be someone on the crew who is truly that engineering specialist. I also hope that this can be the way that I give the most.”
Even though she would be away from her family and husband for an extended period of time, Koch has stated that she hopes to be selected for a mission to Mars in the far future.

In an interview in 2016, she stated, “For Mars, I’d ask my family and friends to make small surprises for me to open on certain days.” “For Mars, I’d ask my family and friends to make small surprises for me to open on designated dates.” After being gone for 15 months, receiving a card that was penned by you can be the finest thing that could ever happen.

Lifestyle News

The first crewed mission to the moon in half a century is called Artemis II, and NASA has now announced its crew of four astronauts.

NASA has revealed the four astronauts who will be participating in the crewed Artemis II mission to the Moon, which will be the first such mission in half a century. NASA astronauts Reid Wiseman, Victor Glover, and Christina Hammock Koch, along with Canadian Space Agency astronaut Jeremy Hansen, are going to take part in a flight test of the Artemis II spacecraft that will last for ten days and will be launched on the powerful Space Launch System rocket in November 2024. The purpose of the test is to validate the capabilities as well as the techniques that are required for humans to live and work in deep space.
The Block 1 version of the Space Launch System will be used to launch the Orion MPCV Spacecraft, which will take the four astronauts into orbit around the moon for a flyby. One of their goals will be to achieve a free return trajectory from the Moon, and they will also aim to perform several departure burns. Orion will be launched into a high Earth orbit after a period of approximately 42 hours. During this time, the crew will perform various checkouts of the spacecraft’s life support systems as well as a proximity operations demonstration using the spent Interim Cryogenic Propulsion Stage (ICPS) as a target. Additionally, the crew will conduct a demonstration of proximity operations.
These individuals, the crew of the Artemis II, will be the first humans to fly to the vicinity of the Moon for the first time in over 50 years, making them the pioneers of this endeavour. All four astronauts will represent the finest of humanity as they explore for the benefit of all people while they are on the moon. The team includes the first woman, the first person of colour, and the first Canadian to go on a lunar mission. According to Director Vanessa Wyche of NASA Johnson, “This mission opens the stage for the expansion of human deep space exploration and presents new prospects for scientific discoveries, commercial, industry, and academic partnerships, and the Artemis Generation.”

News Technology

Because of a widespread problem with their broadband, certain areas of the UK have been cut off.

It managed to completely wreck its own website in a magnificent display of failure.
Users all around the country have reported full failure of internet service for a number of hours, including several of the reporters working at our news desk. This morning, the UK broadband pusher Virgin Media, which is owned by Liberty in the United States, fell down on its face.

Prior to this, readers who notified The Reg were claiming that “their service status reports no issues like it always does.” Nevertheless, earlier today, even its status page was down. It wasn’t until about 8:30 UTC that the website finally got back on its feet.

Cloudflare discovered that the autonomous system number AS5089 belonging to Virgin Media was experiencing a “total internet outage” beginning at 02:30 UTC, since traffic began to decrease at that time. Cloudflare also confirmed that the Virgin Media DNS service was down.

Accordingly, as the network started to come back online, several customers across the country reported that they were able to get online by using a virtual private network (VPN). However, for other customers, the router simply would not connect to the network and repeatedly flashed “various lights as if it was going round and round trying to connect to the mothership.”
Cloudflare discovered that the authoritative nameservers for VM are also located on AS5089, which provides an explanation for the downtime experienced by the nameservers and the website.

According to DownDetector and Twitter, reports began coming in soon after 01:00 local time, with a total of over 27,000, which is only a fraction of the customers that have Virgin Media.

On Twitter, a notspot networker for wavemobile vented their frustration that they’d experienced a problem “Because of @virginmedia, I had a restless night, and they provided NOTHING information or an apology. In the event that something goes wrong, the bare minimum that you can do is notify us through a reputable service page. Would have prevented me from going into the office at three in the morning.”

A representative for Virgin Media stated to The Register that the business was “aware of a problem that is causing disruptions in the broadband services provided to Virgin Media consumers as well as in our contact centres. Our staff are presently working to identify and fix the problem as quickly as possible, and we apologise to all of our customers who have been negatively impacted by this situation.”

IT experts based in the United Kingdom who were planning to get an early start on the weekend or coordinate renovations during the Easter holiday weekend will not have needed this at all.
One reader of the Reg who was very upset with the delay said, “Mind, it took seven hours for them to realise there was a problem!”

Another reader pointed out that contact centres were also inaccessible, which is concerning given the current state of the network’s resiliency “The number 150 on the phone contact redirects to an unavailable number. The Virgin website appears to have reverted to a more “simple” layout recently. Some websites are accessible while others are not.”
After being acquired by the telecommunications behemoth Liberty Global and the Spanish company Telefónica, Virgin Media/O2 released its first full year results as an unified corporation just a month ago. It reported a flat total revenue of £10.38 billion ($12.97 billion), but it was still able to squeeze out more profits from that, as seen by an adjusted post-transaction EBITDA that climbed by 6.3 percent year-on-year to reach £3.9 billion. It announced a dividend payment to shareholders in the amount of £1.6 billion.

The completion of Nexfibre, a joint venture involving Liberty Global, Telefónica, and Infravia, occurred in the month of December. VM, which is an anchor tenant and build supplier of the network, claims that its Virgin Media O2 footprint will be expanded to 80 percent of the UK by the year 2026. At that time, the company hopes to present a “scaled wholesale fibre opportunity” that will compete with Openreach, the company that is currently serving as the nation’s primary broadband plumber.

We have inquired with VM as to the reason why there was no resilience in terms of call centres and its own website. This circumstance seems to indicate that there were failures of network redundancies that should have been built-in. ®

Lifestyle News

Hugh Jackman has disclosed a new skin cancer fear after getting two biopsies, and he is urging others to protect themselves from the sun.

Hugh Jackman has disclosed that, following a recent checkup, he has been undergoing testing to determine whether or not he has skin cancer. The actor, who is best known for his role as Wolverine, has spoken publicly in the past about his battle with skin cancer. In 2013, he had his first skin cancer removed.

The actor, who is 54 years old and starred in “The Greatest Showman,” gave his fans an update on his health by posting a photo to Instagram in which he wore a plaster across his nose.

In the video shared on social media, he disclosed that his physician had observed “small things” on his skin that she believed warranted obtaining a biopsiy to investigate further.


The Australian actor said the following in the caption of his post: “You’ve heard me talk about my basal cell carcinomas in the past. If further discussion is required, I will continue to bring them up. Even if only one person remembers to apply sunscreen with a high SPF, I will consider it a success.

After that, in the brief video, Jackman stated that he wanted his fans to hear it from him in case “someone sees me on the street” sporting a bandage. He said that he wanted his followers to hear it from him in case “someone sees me on the street.”
He revealed, “I’ve just recently had two biopsies performed, and I just went to my doctor, Dr. Iron, who is fantastic, and she just saw some minor things.” In her opinion, a basal cell either may be there or it could not be present; she is unsure. I won’t know for sure for another couple of days, but as soon as I do, I’ll be sure to let you know. As a friendly reminder, basal cells are the least serious type of skin cancer there is. Basal cell carcinoma is the most common type of skin cancer. Nonetheless, if I may just use this occasion to bring it to your attention, summer will soon be here.

“For those of us who are located in the Northern Hemisphere, please remember to apply sunscreen; the potential risks are not worth it.” Trust me, believe me, trust me, regardless of how badly you desire a tan.”
Basal cell carcinoma does not normally spread. It most frequently takes the form of a tiny, bright pink or pearly-white lump that has the appearance of being translucent or waxy. Moreover, it may appear as a scaly red area on the skin.

Once he updated his followers on his health, several of his devotees expressed their gratitude to him for drawing attention to the illness.

One person said in the comment section underneath his video, “Praying it’s nothing. We are grateful that you are using your platform to assist others.

“I am grateful to you for this! Stage 3 melanoma survivor here. Before it happened to me, I had no idea how potentially life-threatening it could be. while someone else made a comment.

The actor best known for his role in Wolverine has spoken publicly about his battle with skin cancer in the past. He had his first skin cancer removed in 2013, and he has had at least six treatments since then.

The film was released by Jackman after it was reported the previous year that the number of people diagnosed with skin cancer in England had reached a record high, with around one in five people developing the disease at some point in their lives.

According to numbers that were analysed by NHS Digital and the British Association of Dermatologists, there were 224,000 cases of skin cancer diagnosed in England in 2019, and more than 1.4 million cases were diagnosed between the years 2013 and 2019.

According to the data, the number of reported cases increased by 26 percent, going from 177,677 in 2013 to 224,092 in 2019.

The majority of experts believe that the increase can be attributed to an ageing population as well as advances in how tumours are reported.